These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31933161)

  • 1. Uric acid in CKD: has the jury come to the verdict?
    Bonino B; Leoncini G; Russo E; Pontremoli R; Viazzi F
    J Nephrol; 2020 Aug; 33(4):715-724. PubMed ID: 31933161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of Nephropathy.
    Mende C
    Adv Ther; 2015 Dec; 32(12):1177-91. PubMed ID: 26650815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial.
    Eleftheriadis T; Golphinopoulos S; Pissas G; Stefanidis I
    J Adv Res; 2017 Sep; 8(5):555-560. PubMed ID: 28748122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperuricemia: An Intriguing Connection to Metabolic Syndrome, Diabetes, Kidney Disease, and Hypertension.
    Vareldzis R; Perez A; Reisin E
    Curr Hypertens Rep; 2024 Jun; 26(6):237-245. PubMed ID: 38270791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonlinearity association between hyperuricemia and all-cause mortality in patients with chronic kidney disease.
    Liu YF; Han L; Geng YH; Wang HH; Yan JH; Tu SH
    Sci Rep; 2024 Jan; 14(1):673. PubMed ID: 38182707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin αM promotes macrophage alternative M2 polarization in hyperuricemia-related chronic kidney disease.
    Liu J; Guo F; Chen X; Fu P; Ma L
    MedComm (2020); 2024 Jul; 5(7):e580. PubMed ID: 38911067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to Demonstrate the Impact of Dapagliflozin on Improving Hyperuricemia in Patients with Chronic Kidney Disease.
    Fujioka H; Kataoka N; Imamura T
    Intern Med; 2024 Jan; ():. PubMed ID: 38171852
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of Allopurinol on the Progression of Chronic Kidney Disease.
    Badve SV; Pascoe EM; Tiku A; Boudville N; Brown FG; Cass A; Clarke P; Dalbeth N; Day RO; de Zoysa JR; Douglas B; Faull R; Harris DC; Hawley CM; Jones GRD; Kanellis J; Palmer SC; Perkovic V; Rangan GK; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW;
    N Engl J Med; 2020 Jun; 382(26):2504-2513. PubMed ID: 32579811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection.
    Kielstein JT; Pontremoli R; Burnier M
    Curr Hypertens Rep; 2020 Oct; 22(12):102. PubMed ID: 33128170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of uric acid: hyperuricemia and hypouricemia.
    Park JH; Jo YI; Lee JH
    Korean J Intern Med; 2020 Nov; 35(6):1291-1304. PubMed ID: 32872730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2020 American College of Rheumatology Guideline for the Management of Gout.
    FitzGerald JD; Dalbeth N; Mikuls T; Brignardello-Petersen R; Guyatt G; Abeles AM; Gelber AC; Harrold LR; Khanna D; King C; Levy G; Libbey C; Mount D; Pillinger MH; Rosenthal A; Singh JA; Sims JE; Smith BJ; Wenger NS; Bae SS; Danve A; Khanna PP; Kim SC; Lenert A; Poon S; Qasim A; Sehra ST; Sharma TSK; Toprover M; Turgunbaev M; Zeng L; Zhang MA; Turner AS; Neogi T
    Arthritis Care Res (Hoboken); 2020 Jun; 72(6):744-760. PubMed ID: 32391934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric Acid and CKD Progression Matures with Lessons for CKD Risk Factor Discovery.
    Oluwo O; Scialla JJ
    Clin J Am Soc Nephrol; 2021 Mar; 16(3):476-478. PubMed ID: 33055190
    [No Abstract]   [Full Text] [Related]  

  • 13. 2020 American College of Rheumatology Guideline for the Management of Gout.
    FitzGerald JD; Dalbeth N; Mikuls T; Brignardello-Petersen R; Guyatt G; Abeles AM; Gelber AC; Harrold LR; Khanna D; King C; Levy G; Libbey C; Mount D; Pillinger MH; Rosenthal A; Singh JA; Sims JE; Smith BJ; Wenger NS; Bae SS; Danve A; Khanna PP; Kim SC; Lenert A; Poon S; Qasim A; Sehra ST; Sharma TSK; Toprover M; Turgunbaev M; Zeng L; Zhang MA; Turner AS; Neogi T
    Arthritis Rheumatol; 2020 Jun; 72(6):879-895. PubMed ID: 32390306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage.
    Ejaz AA; Nakagawa T; Kanbay M; Kuwabara M; Kumar A; Garcia Arroyo FE; Roncal-Jimenez C; Sasai F; Kang DH; Jensen T; Hernando AA; Rodriguez-Iturbe B; Garcia G; Tolan DR; Sanchez-Lozada LG; Lanaspa MA; Johnson RJ
    Semin Nephrol; 2020 Nov; 40(6):574-585. PubMed ID: 33678312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating Hyperuricemia: The Last Word Hasn't Been Said Yet.
    Russo E; Verzola D; Leoncini G; Cappadona F; Esposito P; Pontremoli R; Viazzi F
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric acid and cardiovascular disease: A clinical review.
    Saito Y; Tanaka A; Node K; Kobayashi Y
    J Cardiol; 2021 Jul; 78(1):51-57. PubMed ID: 33388217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective.
    Yu W; Cheng JD
    Front Pharmacol; 2020; 11():582680. PubMed ID: 33304270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of uric acid in inflammasome-mediated kidney injury.
    Braga TT; Foresto-Neto O; Camara NOS
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):423-431. PubMed ID: 32452918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid and inflammation in kidney disease.
    Jung SW; Kim SM; Kim YG; Lee SH; Moon JY
    Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1327-F1340. PubMed ID: 32223310
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.